Previous 10 | Next 10 |
home / stock / mdx:cc / mdx:cc news
MedX Health Corp. (“ MedX ” or the “ Company ”) ( TSXV: MDX ), a global leader in teledermatology, is pleased to announce that it has completed the First Closing of Secured Convertible Debentures previously announced in its Press Release dated January 30, 2...
MedX Health Corp. (“ MedX ” or the “ Company ”) ( TSXV: MDX ), a global leader in teledermatology, is pleased to announce that, further to its Press Release dated November 18, 2022, it has closed a private placement financing to raise $1.5 million by issuan...
MedX Health Corp. (“ MedX ” or the “ Company ”) ( TSXV: MDX ), a global leader in teledermatology, is pleased to announce that it is proposing to complete a private placement financing to raise up to $1.5 million by issuance of a Secured Convertib...
MedX Health Corp. (“ MedX ” or the “ Company ”) ( TSXV: MDX ), a global leader in teledermatology, is pleased to announce that on October 21, 2022 it finalized Closing of the private placement of Series III Convertible Loan Notes (“ Serie...
MedX Health Corp. (“ MedX ” or the “ Company ”) (TSXV: MDX) is pleased to announce that, in connection with the Private Placement (the “ Financing ”), and further to the $250,000 first tranche closing of which was announced in its Pr...
MedX Announces Tarek El Hoss as Sr. Vice President, Market Development and Sales MedX Health Corp. (“ MedX ” or the “ Company ”) ( TSXV: MDX ), a global leader in teledermatology, is pleased to announce that Tarek El Hoss has been ...
MedX Health has partnered with Central Health, the second largest health authority in Newfoundland and Labrador, to introduce DermSecure ® Screening Platform Services to 176 communities across the province. MedX Health Corp. ("MedX" or the "Company") (TS...
MedX Health Corp. (“ MedX ” or the “ Company ”) (TSXV: MDX ) is pleased to announce that it has closed on the First tranche, of $250,000, of the non-brokered Private Placement announced in its Press Release of June 30, 2022. The Placement ...
MedX Health Corp. (“ MedX ” or the “ Company ”) (TSXV: MDX ) is pleased to announce that it has made an amendment to the terms of the non-brokered Private Placement previously announced in its News Release dated June 30, 2022. The private plac...
MedX Health Corp. (“ MedX ” or the “ Company ”) (TSXV: MDX ) is pleased to announce that it is proposing a non-brokered Private Placement to accredited investors of up to $4 million by issuance of up to 80 Series III Convertible Loan Notes, ea...
News, Short Squeeze, Breakout and More Instantly...
MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V: MDX) announces that it has completed the Initial Closing of the Private Placement originally announced on May 1, 2024, by issuance of 7,142,856 Units (as described below) to raise $500,000. A cash commissi...
MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V: MDX) announced today that, subject to acceptance by the TSX-V, the ultimate Closing Date for the non-brokered Private Placement of up to $2 million, which was previously announced on May 1, 2024, will be e...
MedX Health Corp. (MDX:CA) is expected to report for Q1 2024